Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560871 | 12756087 | 1 | I | 20160913 | 20160916 | 20160916 | EXP | US-UCBSA-2016035334 | UCB | 4.00 | YR | F | Y | 0.00000 | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560871 | 12756087 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 3.5ML | U | U | 21035 | |||||||||
| 127560871 | 12756087 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | INCREASED DOSE | U | U | 21035 | |||||||||
| 127560871 | 12756087 | 3 | C | DIASTAT | DIAZEPAM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127560871 | 12756087 | 1 | Product used for unknown indication |
| 127560871 | 12756087 | 3 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127560871 | 12756087 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127560871 | 12756087 | Dyspnoea | |
| 127560871 | 12756087 | Generalised tonic-clonic seizure | |
| 127560871 | 12756087 | Petit mal epilepsy | |
| 127560871 | 12756087 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |